- Home
- BFS vs PRAX Comparison
BFS vs PRAX Comparison
Compare BFS & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFS
- PRAX
- Stock Information
- Founded
- BFS 1993
- PRAX 2015
- Country
- BFS United States
- PRAX United States
- Employees
- BFS N/A
- PRAX N/A
- Industry
- BFS Real Estate Investment Trusts
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- BFS Real Estate
- PRAX Health Care
- Exchange
- BFS Nasdaq
- PRAX Nasdaq
- Market Cap
- BFS 985.6M
- PRAX 1.2B
- IPO Year
- BFS 1993
- PRAX 2020
- Fundamental
- Price
- BFS $40.25
- PRAX $74.92
- Analyst Decision
- BFS Strong Buy
- PRAX Strong Buy
- Analyst Count
- BFS 1
- PRAX 9
- Target Price
- BFS $45.50
- PRAX $144.11
- AVG Volume (30 Days)
- BFS 72.4K
- PRAX 295.5K
- Earning Date
- BFS 10-31-2024
- PRAX 11-05-2024
- Dividend Yield
- BFS 5.83%
- PRAX N/A
- EPS Growth
- BFS 8.84
- PRAX N/A
- EPS
- BFS 1.78
- PRAX N/A
- Revenue
- BFS $264,084,000.00
- PRAX $1,771,000.00
- Revenue This Year
- BFS N/A
- PRAX N/A
- Revenue Next Year
- BFS $6.21
- PRAX N/A
- P/E Ratio
- BFS $22.85
- PRAX N/A
- Revenue Growth
- BFS 5.56
- PRAX 20.97
- 52 Week Low
- BFS $33.56
- PRAX $13.01
- 52 Week High
- BFS $42.19
- PRAX $75.73
- Technical
- Relative Strength Index (RSI)
- BFS 45.67
- PRAX 71.35
- Support Level
- BFS $39.54
- PRAX $60.73
- Resistance Level
- BFS $41.19
- PRAX $65.87
- Average True Range (ATR)
- BFS 0.64
- PRAX 3.85
- MACD
- BFS -0.11
- PRAX 1.22
- Stochastic Oscillator
- BFS 26.79
- PRAX 96.03
About BFS Saul Centers Inc.
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates, and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.